Dopaminergic agonists in Parkinson's disease-Reference-Cited by-同舟云学术

Dopaminergic agonists in Parkinson's disease

Published:2014-05 Issue:4 Volume:29 Page:230-241
ISSN:2173-5808
Container-title:Neurología (English Edition)
language:en
Short-container-title:Neurología (English Edition)

Author:

Alonso Cánovas A.,Luquin Piudo R.,García Ruiz-Espiga P.,Burguera J.A.,Campos Arillo V.,Castro A.,Linazasoro G.,López Del Val J.,Vela L.,Martínez Castrillo J.C.

Publisher

Elsevier BV

Subject

General Materials Science

Reference61 articles.

1. Pharmacology of dopamine agonists in the treatment of Parkinson's disease;Jenner;Neurology,2002

2. Long-term studies of dopamine agonists;Hubble;Neurology,2002

3. Pharmacology of pramipexole, a dopamine D3 preferring agonist useful in treating Parkinson's disease;Piercey;Clin Neuropharmacol,1998

4. Pramipexole extended release: in Parkinson's disease;Chwieduk;CNS Drugs,2010

5. Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease;Perez Lloret;Expert Opin Pharmacother,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part I: exploring theoretical insights and pharmacological advances;Expert Opinion on Drug Delivery;2024-03-03

2. Safety of opicapone use in Parkinson’s disease: review of literature and real-world safety data;World Journal of Current Medical and Pharmaceutical Research;2023-10-03

3. Dietary Restriction against Parkinson’s Disease: What We Know So Far;Nutrients;2022-10-03

4. Recent advances in dopamine D ₂ receptor ligands in the treatment of neuropsychiatric disorders;Medicinal Research Reviews;2022-09-16

5. Parkinsonian syndrome after chikungunya: A case study;International Journal of Case Reports and Images;2022